ARCHIVES

Halterman, Mahoney And Their Grants Go To DCT, Along With Some Program Projects

This article is from The Cancer Letter archive.

Vol. 04 No. 11 | March 17, 1978

Download PDF Visit The Full Archive

Related Articles

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

November 18, 2011

Patient Advocacy: FDA, NCI Developing Methods For Naming Survivors To Boards

February 7, 1997

Bladder Cancer Epidemiological Study Involves 3,000 Patients

March 2, 1979

GAO: FDA Data On Drug Shortages Inadequate

February 21, 2014

Zevalin Regimen Better Than Rituximab Alone For NHL

June 29, 2001

Trial Combines Drugs Against Blood Vessel Formation

October 26, 2007